多发性硬化症发作的发作及其在疾病进展中的作用
Matthias Grothe1, David Ellenberger2, Paulus S Rommer3,4
1Department of Neurology, University Medicine Greifswald, Ferdinand-Sauerbruchstraße, Greifswald 17475, Germany.
Therapeutic advances in neurological disorders
|October 9, 2023
概括
多发性硬化症 (MS) 发作的发作与更大的长期残疾进展有关. 这项研究强调了在MS患者的治疗和预后中考虑早期发作的重要性.
科学领域:
- 神经学 神经学
- 神经免疫学 神经免疫学
- 临床研究 临床研究
背景情况:
- 发作是已知的多发性硬化症 (MS) 的并发症.
- 以前的研究表明,发作与MS患者随着时间的推移增加的残疾相关.
- 发生在MS发作初期的发作对长期残疾进展的影响仍然不清楚.
研究的目的:
- 为了研究在多发性硬化症 (MS) 开始时发生的发作和随后的疾病进展之间的关系.
- 为了确定在发作时经历发作的多发性硬化患者与没有发作的患者相比,是否表现出不同的残疾轨迹.
主要方法:
- 一项病例控制研究分析了15年来德国多发性硬化病登记册中30713名患者的数据.
- 在MS发作时出现的患者被确定并与没有发作时出现的对照人群进行比较.
- 亚组分析检查了多症状与单症状发作的发作患者.
主要成果:
- 46名患者最初的MS症状是发作.
- 在发作时患有发作的MS患者最初的扩大残疾状态量表 (EDSS) 分数较低 (0.75对1.6),但随着时间的推移显示EDSS进展增加 (3.11对3.0).
- 与对照组相比,多症状和单症状的发作发作小组都表现出加速的残疾进展.
结论:
- 在多发性硬化症开始时发生的发作与明显更高的残疾进展有关.
- 这些发现强调了MS中早期发作的预后重要性.
- 需要进行进一步的纵向研究,以充分阐明发作在MS进展中的病理生理学作用.
相关概念视频
01:24Arteries of the Lower Limbs
198
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
198
01:13Seizures: Classification
384
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
384
01:14Antiepileptic Drugs: Glutamate Antagonists
393
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
393
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
430
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
430
01:15Parkinson's Disease: Overview
587
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
587
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
322
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
322